Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

Gastroenterology

Volumn 108, Issue 1, 1995, Pages 165-171

  Wong, David K H ^a   Yim, Colina ^a   Naylor, C David ^a   Chen, Erluo ^a   Sherman, Morris ^a   Vas, Stephen ^a   Wanless, Ian R ^a   Read, Stanley ^a   Li, Helen ^a   Heathcote, E Jenny ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALANINE AMINOTRANSFERASE; ALPHAN1 INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEPATITIS B; HOMOSEXUALITY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INFLUENZA; MALE; MONONUCLEAR CELL; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; VIRUS REPLICATION;

EID: 0028813488     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90021-7     Document Type: Article

References (24)

1. Progress on the control of hepatitis B infection through immunization
2. Notifiable diseases summary
3. National Advisory Committee on Immunization statement on hepatitis B vaccine
4. Survival in chronic hepatitis B
5. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
6. Biological basis for the clinical use of interferon
7. Interferon-associated lymphocyte 2′,5′-oligoadenylate synthetase in acute and chronic viral hepatitis
8. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B
9. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy?
10. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection
11. The hepatitis B carrier state—a follow-up study of 100 consecutive cases
12. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection
13. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum
14. Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen serconversion in chronic type B hepatitis
15. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults
16. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study
17. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
18. Experience with interferon in chronic hepatitis B in Egypt
19. Randomised controlled trial of lymphoblastoid interferon alfa in European men with chronic hepatitis B virus infection
20. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy
21. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection
22. Gron alfa-2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response
23. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
24. Long-term remission of chronic hepatitis B after alpha-interferon therapy